Parkwood LLC’s Immunogen Inc IMGN Stock Holding History

Parkwood LLC’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,826	Closed	-$766K	–	207
2023 Q4	$766K	Buy	+25,826	New	+$514K	0.09%	97
2022 Q4	–	Sell	-52,000	Closed	-$249K	–	183
2022 Q3	$249K	Buy	+52,000	New	+$274K	0.04%	134
2022 Q2	–	Sell	-77,233	Closed	-$368K	–	176
2022 Q1	$368K	Buy	+77,233	New	+$428K	0.06%	108
2021 Q3	–	Sell	-64,924	Closed	-$428K	–	135
2021 Q2	$428K	Buy	+64,924	New	+$453K	0.05%	111
2017 Q3	–	Sell	-12,480	Closed	-$89K	–	401
2017 Q2	$89K	Buy	+12,480	New	+$57.1K	0.01%	415

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Parkwood LLC's IMGN Position: Q1 2024 in Review

Parkwood LLC sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 25,826 shares — an estimated $766K sold.

Parkwood LLC first reported a position in IMGN in Q2 2017 and held it in 5 quarters. The position peaked at $766K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Parkwood LLC reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Parkwood LLC sold 25,826 Immunogen Inc shares in Q1 2024, an estimated $766K.
Parkwood LLC first reported a position in Immunogen Inc in Q2 2017 and held it in 5 quarters.
Parkwood LLC's Immunogen Inc position peaked at $766K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Parkwood LLC's 13F filing for Q1 2024, filed 15 May 2024.